key: cord-0926122-nbefav50
authors: Dai, Tieying; Zhang, Leyin; Dai, Xinyang; Zhang, Xinran; Lu,, Beibei; Zheng, Yuxi; Shen, Deyi; Yan, Yici; Ji, Congqi; Yu, Jieru; Sun, Leitao
title: Multimode Participation of Traditional Chinese Medicine in the Treatment of COVID-19
date: 2021-10-07
journal: Integr Med Res
DOI: 10.1016/j.imr.2021.100781
sha: 08bbd6c85aa7d8b46dce57ed25f71313e3831be6
doc_id: 926122
cord_uid: nbefav50

BACKGROUND: : The outbreak of COVID-19 has swiftly spread across China and all over the world, resulting in severe contagious pneumonia. However, no specific anti-COVID-19 drugs or methods are available for the treatment of this acute and fatal disease. In recent years, as the efficacy and safety of traditional Chinese medicine (TCM) have been universally acknowledged, it has been brought to a crucial status domestically and overseas for the treatment of COVID-19. METHODS: : We searched relevant literature, electronic databases, and official statements, diagnoses and protocols to retrieve studies and applications related to traditional Chinese medicine for COVID-19 in terms of regulations and policies, clinical evidence, preclinical rationale and big data analysis and then summarized the discovery and development of potential drugs and their targets. RESULTS: : Clinicians, researchers, governments, the public, colleges, institutes and companies collected and classified associated policies, regulations and actual contributions, searched clinical trials and preclinical experimental outcomes from databases, studied potential TCM drugs with possible mechanisms, retrieved numerous big data analysis method and gathered pooled results of compounds along with their effective targets to make traditional Chinese medicine vital to cover all stages of patients in the treatment and control of COVID-19. CONCLUSION: : Traditional Chinese medicine provides new evidence to support the clinical value of TCM for COVID-19.

Coronavirus disease 2019 (COVID- 19) , an epidemic disease, has spread across the planet since 3 . Therefore, the original syndrome differentiation and treatment system can be used for treatment, and no new theory is required. In terms of treatment, modern medicine mainly aims to find direct antiviral drugs to kill and inhibit the virus. This idea requires us to find specific drugs with antiviral effects 4 . From the perspective of TCM, TCM treats the patient and the virus as a whole and differentiates treatment from the initial, middle, severe and recovery phases according to the progress and symptoms of the whole. In terms of medication, from the perspective of modern medicine, it takes a long time to find specific antiviral drugs, which requires in vitro experiments and confirmation of clinical experiments. In vitro experimental results alone without clinical trial confirmation cannot prove the ultimate effectiveness. Therefore, in the section on antiviral drugs in the national version of the diagnosis and treatment plan, the word 'trial' is clearly stated 5 . In contrast, there have been many times in the history of the development of Chinese medicine where TCM has fought and competed with epidemics 6 . For example, during the SARS period, Western medicine did not have a specific medicine for the SARS virus. TCM has corresponding effective prescriptions for prevention, treatment, and prognosis. It has accumulated valuable experience and resulted in many books and prescriptions. All TCMs are effective and are not trial medicines 7 .

With the progression of the COVID-19 epidemic, there have been a wide range of efforts made by -5 -clinicians, researchers, governments, the public, colleges, institutes and companies to make TCM vital to cover all stages of patients with COVID-19 8 . Therefore, we attempt to provide a timely and comprehensive review of the rapidly increasing number of publications on COVID-19, including TCM-related regulations and policies, clinical evidence, preclinical outcomes and big data analysis, which thus hold the promise to bring new strategies for the treatment and control of COVID-19. We screened the papers and reports we needed according to the titles or abstracts and then organized them in chronological order. We extracted three parts of information from them: policy support, diagnosis and treatment protocol and TCM practitioners' actions.

Domestic and foreign clinical trial registration databases, such as the Chinese Clinical Trial Registry (ChiCTR) and Clinical Trials.gov, were searched with the keywords mentioned above. We extracted, on the one hand, data from the clinical trials themselves, including drugs and means of intervention, sample size, institution and region. On the other hand, we fetched the outcome of a clinical trial covering the degree of completion and the rate of positive results obtained.

Electronic databases mentioned above were searched with the keywords consisting of 'basic research' and 'experiment' as well as the words mentioned above to look for the results of preclinical and big data analysis. In basic research, we summarized the potential mechanism of TCM against coronavirus. In big data analysis, we collated the drug targets and active components in the bioinformation analysis. After the outbreak of the epidemic, the central government of China attached great importance to the outbreak and quickly carried out relevant work.

At the beginning of the epidemic, the central government issued many policies and instructions.

As early as January 22, 2020, the State Administration of Traditional Chinese Medicine (SATCM) established a leading COVID-19 prevention and control group and an expert group to analyze and evaluate the progress of the epidemic, formulate TCM treatment plans, collect and treat cases, and propose scientific research needs and priority areas for TCM 9 . The SATCM not only held a meeting to emphasize the complementarity of traditional Chinese and Western medicine but also jointly issued several notices with the National Health Commission (NHC) repeatedly requiring TCM hospitals to continuously further improve prevention and control. Several provinces responded positively, such as Beijing, which not only integrated TCM clinical and scientific research but also implemented an emergency filing of TCM preparations to promote the transformation of clinical achievements 10 .

Subsequently, various self-prescribed TCM preparations were approved, provincial medical insurance bureaus such as Shanxi issued plans to fully reimburse these TCM preparations, and other TCMs commonly used to treat COVID-19 were reasonably formulated to determine the self-payment proportion 11 .

With the aggravation of COVID-19 abroad, China provided TCM-related support and donated proprietary Chinese patent medicine and prescriptions, such as Lianhua Qingwen capsules, Jinhua Qinggan granules, Huashi Baidu formula and acupuncture needles, to more than 10 countries, such as Iraq and Italy 12 . In addition, China translated TCM diagnosis and treatment protocols, shared TCM experience and correlational studies through videos and international forums to over 60 countries worldwide 13 , and sent 37 anti-epidemic medical teams with the participation of TCM practitioners to 34 countries 14, 15 .

As we enter the post epidemic era, an increasing number of sequelae have gradually appeared in patients who were completely cured, with more than 200 symptoms involved in various system -7 -organs, but Western medicine has been unsuccessful in controlling these symptoms effectively 16 . At this moment, suggestions such as integrated traditional Chinese and Western medicine methods should be actively adopted for the prevention and treatment of sequelae, and TCM mind-body treatments such as Baduanjin, Tai Chi or rehabilitation exercises of TCM should also be popularized energetically, have been brought up. 17 Furthermore, the NHC required all provinces to explore ways to use TCM for sequela prevention and treatment and to summarize relevant experiences.

Moreover, the central government has issued several versions of COVID-19 diagnosis and treatment plans to guide TCM practitioners. On January 23, 2020, the NHC and SATCM first formally 

A TCM team and tens of thousands of TCM practitioners also actively participated in clinical treatment. After the outbreak, the SATCM immediately sent an expert group to Wuhan for early -8 -intervention with TCM. Then, more than 630 TCM hospitals in 28 provinces sent more than 4900 TCM practitioners by March 2020, accounting for approximately 13% of the total number of medical personnel assisting Hubei 23 . The SATCM sent five TCM medical teams successively, with a total of 773 people, including 2-3 experts assigned to 16 

From current treatment results, TCM has been suggested to be effective for COVID-19 in clinical practice 28, 29 . According to clinical investigation, TCM treatments are accepted by approximately 80% and 90% of severe and mild patients, respectively. Even for those who are in quarantine, there were also many expectations to fight COVID-19 by TCM intervention, and its satisfaction accounts for approximately 70% of the visit results. To find more specific and effective compounds and some external treatments and to promote and publicize the efficacy of TCM, clinicians have carried out many clinical trials related to TCM. clinical trials for the following reasons. First, many of the registered trials are retrospective rather than prospective clinical trials 32 , so the conclusions lack representativeness. Then, some are single-arm experiments, and it is difficult to judge the treatment effect without contrast 33 . Third, the sample size of clinical trials is too small or inappropriate 34 , which makes the difference in outcome indicators lose statistical significance. Furthermore, some clinical trials lack random, blinding or allocation concealment designs, inconsistent baseline characteristics, unstandardized or later evaluation and -10 -intervention, and long-term follow-up. Moreover, the selection of outcome indicators is unreasonable, and ethical issues are not fully considered. Additionally, in the exploratory study, the risk of patients receiving ineffective treatment was increased, and because patients were unable to participate in other studies, the chance of receiving potentially effective treatment was reduced. Finally, the effect of TCM is not particularly significant, which enlarges the influence of the above reasons on the experimental effective data.

However, reliable conclusions could be drawn from the following studies, which can provide support for the diagnosis and treatment guidelines of COVID-19. Qingfei Paidu decoction, as a special prescription for the general treatment of cold dampness epidemic disease, has achieved significant clinical effects in COVID-19 clinical trials. In a clinical trial of 295 mild/common type COVID-19 patients in Wuhan treated with Qingfei Paidu decoction, Qingfei Paidu decoction helped relieve the mild and common symptoms of COVID-19 patients, improving the outcome of chest CT imaging.

Qingfei Paidu decoction alone has certain advantages over drug combined treatment in terms of average hospital stay, negative nucleic acid conversion time, advancements in sputum symptoms, and improvement in chest CT outcome 35 . Lianhua Qingwen, a CHM compound preparation based on the prevention and treatment theory of TCM on 'plagues', shows prominent efficacy in clinical trials. A paper on the clinical trial of Lianhua Qingwen for COVID-19 has been published. 36 Conducted in February 2020 in 23 hospitals in China, 284 patients in this trial were enrolled in an objective randomized parallel controlled trial design. Patients were randomly assigned to receive either conventional treatment alone or a combination of conventional treatment and Lianhua Qingwen capsules and a control group. This clinical trial is the first prospective, multicenter, open-label randomized controlled trial (RCT) using TCM to treat novel coronavirus, as reported by an international journal. The results showed that the duration of fever, fatigue, and cough in patients with COVID-19 was shortened by 1, 3 and 3 days, respectively. The recovery rate increased to 91.5%, which was significantly higher than that in the control group. Furthermore, two experiments on the treatment of COVID-19 with a Gengzi No. 3 prescription and Jinbei oral liquid showed that they could improve the symptoms of the disease, promote the recovery of the disease, and significantly shorten the course of the disease, according to the nucleic acid negative time, CT improvement rate, total -11 -course of disease and other indicators 37, 38 . In addition, the trial results showed that the Jinqiang Xuanfei Jiedu mixture was effective in treating mild and moderate cases of COVID-19 39 .

Despite its clinical efficacy and safety for COVID-19 and its tendency to delay disease progression, TCM has not been recognized internationally. This is mainly because research on CHM ingredients is insufficient to provide scientific experimental evidence, such as the content of the main ingredients and the target of action; in addition, TCM syndrome differentiation emphasizes the individualization of treatment, so it is difficult to achieve standardization, which also limits the application of TCM in a wider range. To gain international recognition and application, more prospective cohort studies are needed, and there are many suggestions. First, we should concentrate on the implementation of promising multicenter major trials and organize large-scale clinical trials with effective data by using the support of the government and society. Next, clinical trials that are not promising 40 , such as those that were allowed to proceed based on data from in vitro cell studies during the COVID-19 pandemic, should be rejected. Furthermore, large-scale clinical trials should be led by professionals, and more frontline doctors should be encouraged to participate in clinical research. In addition, RCTs with rigorous designs and large samples are urgently needed to provide reliable evidence of the therapeutic effect of TCM for the treatment and prevention of COVID-19. Ultimately, with the implementation of these measures, the quality of TCM clinical trials will be improved, which will provide scientific and credible research evidence for the clinical efficacy of TCM and better promote the development of TCM.

Drug targets are the source of drug action and the most important biological basis for drug treatment of diseases. For a long time, due to the complex characteristics of its own components, revealing the target and the molecular pharmacological mechanism of TCM has not achieved breakthrough progress, which has seriously restricted the modernization and internationalization of TCM. Since then, with the development of frontier disciplines, people have constantly explored and established a series of identification methods for drug targets. The following is a summary of basic research and big data target research 41 .

-12 -

In terms of clinical therapeutic effects, applying TCM to patients with coronaviruses (CoVs) has been confirmed to have potential anti-CoV effects and provides support to identify more drugs and targets to fight COVID-19 42 . Furthermore, the clinical benefit of TCM should also be supported by basic research.

Among the potential anti-CoV targets, most of them are coexpressed with ACE-2, the host receptor of CoVs, which indicates that CHMs targeting ACE-2 that block CoV S-mediated cell fusion are expected to prevent CoV infection for viral entry 43 . For example, isorhamnetin 44 , corilagin 45 , ephedrine (EP), pseudoephedrine (PEP) and methylephedrine (MEP) from Ephedra sinica 46 , platycodin D from Platycodon grandiflorum 47 , proanthocyanidin C1 from Uncaria tomentosa (cat's claw) 48 , and caffeic acid from Sambucus Formosana Nakai 49 all effectively compete for the binding site of the S protein with ACE-2 to inhibit SARS-CoV infection.

In addition to ACE-2, the surface structural spike protein (S) of CoVs is of great importance for antiviral activity due to its essential role in the binding of viruses entering host cells during the infection process, which is responsible for virus-cell receptor interaction and membrane fusion 50, 51 .

Tanshinones from S. miltiorrhiza 52 and fangchinoline, tetrandrine, and cepharanthine from Stephania tetrandra 53 have potential anti-CoV effects by inhibiting the S protein, which blocks viral entry at the early stage of viral infection.

CoV enzymes control viral replication and serve as potential anti-CoV targets for TCM development to combat COVID-19. For example, 3C-like protease (3CLpro) and papain-like protease (PLpro) play a vital role in the transcription and replication of viruses 54 ; thus, enzyme inhibitors targeting these proteases are likely to show inhibitory effects on CoVs. Epigallocatechin-3-gallate 55 , bioflavones and gas from Ginkgo biloba leaf extract (GBLE) 56 , baicalin from Shuanghuanglian preparations 57 , extracts from S. miltiorrhiza 58 , Rhizoma cibotii 59 and Torreya nucifera 60 , herb-derived products that exhibited antiviral activity against SARS-CoV 3CLpro, and tanshinones were also proven to be PLpro inhibitors in vitro 58 .

-13 -Additionally, viral envelope (E), membrane (M), nucleocapsid (N) and accessory proteins also have the function of promoting viral replication and might be potential anti-CoV targets for further Chinese herbal medicine (CHM) development to suppress COVID-19. Examples of resveratrol, which restrain MERS-CoV infection and prolong cellular survival, were proven to induce MERS-CoV apoptosis by decreasing the expression of the N protein 61 . In addition, fangchinoline, tetrandrine, and cepharanthine also target the N protein to inhibit CoV replication 53 . Emodin, a compound extracted from Rheum palmatum, has an inhibitory effect on virion release during the viral replication cycle by suppressing cation-selective channel formation, which plays a role by targeting the SNE-encoded accessory 3a protein 62 . In addition to single herbs, the Biosafety Laboratory conducted animal experiments. They found that Chaiyin granules, Keqing capsules, Kesuting syrup and matrine sodium chloride injections significantly increased the proportion of CD4 + T lymphocytes, CD8 + T lymphocytes and B lymphocytes in peripheral blood [66] [67] [68] . For Chinese patent medicine, Nan and his colleague 63 reported that Sheng Jiang San could also improve the percentage of CD4 + T cells, CD8 + T cells and B cells.

Cytokine storm syndrome (CSS), as a late complication of critically ill COVID-19, is connected -14 -with disease severity and even contributes to many deaths [69] [70] [71] . The major reason for CSS is that the immune system continues to be stimulated, and this prolonged stimulation causes an uncontrolled immune response among T lymphocytes, resulting in overwhelming release of proinflammatory cytokines in host cells 72 , which indicates that alleviating excessive immune responses and eliminating inflammation by specifically targeting relevant cytokines and their host receptors might be an effective way to combat COVID-19 73 . The expression of proinflammatory cytokines such as IL-6, IL-10, CCL-2/MCP-1, CXCL-10/IP-10, TNF-α and IFN-γ was detected to evaluate their anti-inflammatory effect.

Phillyrin (KD-1) and Lianhuaqingwen capsules markedly reduced proinflammatory cytokine production at the mRNA level 36, 74 . Compounds from the Qingfei Paidu decoction, Shufeng Jiedu capsules and Liu Shen capsules may directly interfere with regulating downstream signaling pathways, leading to the inhibition of the release of proinflammatory factors 75, 76 . Researchers also showed that one major compound in the Ma Xing Shi Gan decoction, Glycyrrhizic acid, inhibited TLR agonistinduced IL-6 production in macrophages 77 .

Recently, with the development of network targets and their applications in TCM, network pharmacology has been one of the new strategies for novel drug discovery based on single-target drug studies. By performing network pharmacology analysis, in line with the ADME screening index, such as oral bioavailability and drug likeness index, the potent targets of active compounds against COVID-19 and their related signaling pathways were preliminarily determined to establish an 'herbcompound-target-pathway' network, which aims to explore the possibility of CHMs acting on COVID-19 by analyzing the pathways based on bioinformatics annotation and interactions among targets 78 .

In this way, abundant prescriptions have proven to be effective due to their targets and pathways offering antiviral benefits. In addition to data mining alone, analysis of specific targets and relevant pathways could be performed when combined with network pharmacology. For instance, Wang and her colleague collected published Chinese herbal formulas for COVID-19 with the help of the cloud platform of ancient and modem medical records, then summarized the syndrome patterns, four qi and five flavors, and thus preliminarily acquired a core Chinese herbal formula. Meanwhile, a further -15 -search was conducted to determine the active components and action targets of the core Chinese herbal formula by the Traditional Chinese Medicine System Pharmacology Analysis Platform (TCMSP) 79 .

Molecular docking, as a method of direct drug design, is relatively mature in computer-aided drug design. The actual material method uses computer technology to simulate the geometric structure and intermolecular interactions of molecules through chemical quantitative methods, to study the particle size between molecules and to find small particles. The low-energy mode between molecules (or ligands) and macromolecules (or binding) of known structures is determined in this process 80 . For example, researchers performed molecular docking verification on the active ingredients obtained by screening the crystal structures of SARS-COV-2 3CL hydrolase and ACE2. SYBYL-X.v1.3 software was used to optimize proteins and small molecules, and the SurflexDock module was used for molecular docking. According to the Total-Score scoring function, the interaction between the active ingredient and the target protein was scored. The larger the TotalScore value is, the better the matching and binding effect of the small-molecule compound and the large-molecule protein. With a total score>5 as the threshold, the two groups with the lowest binding energy for each protein were plotted using PyMOL software to plot the best results 81 .

The results from data analysis are of importance to the clinical application of TCM. Studies have faster access to summarize a certain amount of knowledge on classic drugs and screen potential drugs by using data analysis. However, the internal regulation of the body has a more complicated regulatory mechanism than a simple concatenation of targets and signaling pathways. Therefore, the actual effect of TCM cannot be identified with direct targeting but is affected by indirect regulation, such as bypass regulation and cross-talk. This means that there is a need to give treatments based on syndrome differentiation and modifications according to symptoms in terms of the actual situation.

From single internal treatment to multimode combination. External TCM treatment is a TCM method other than internal Chinese medicine. The main mechanism of the therapy is the application of noninternal Chinese medicine to the human body through the special effect of Chinese medicine, -16 -meridian and acupoint. The therapy takes effect from the outside to the inside, unblocks meridians and collaterals, and adjusts the viscera, with the same effect as the internal Chinese medicine treatment of diseases, and even the efficacies of some external treatment methods are better than the efficacy of internal Chinese medicine. The main types of applications in the epidemic are acupuncture, moxibustion, massage, pain compliance, auricular pressure, acupoint patching, TCM and health and wellness methods 82 , which have a solid theoretical foundation, simple practical operation, definite clinical curative effect and easy acceptance by patients. External therapy is mainly used in the rehabilitation treatment and prognosis recovery, which can enhance the body's immunity, support healthy qi, and promote recovery.

From curing COVID-19 to sequela treatment and prevention. COVID-19 has been raging around the world for more than a year, and reports about sequelae are not uncommon, especially in some overseas countries. It was once mentioned that after the treatment of COVID-19, the probability and severity of sequelae is higher in European and American countries than in China 83 . One of the reasons is the difference in treatment methods. China mainly adopts the mode of integrated traditional Chinese and Western medicine, and TCM accounts for a relatively large proportion of this fight against the epidemic. Without specific drugs, European and American countries that adopt modern medical methods can only use antiviral drugs, antibiotics and hormones 84 . These drugs can aggravate some long-term symptoms, mainly sequelae. The sequelae of COVID-19 manifest in multisystem damage and may have symptoms such as long-term weight loss, general fatigue, and abnormal liver and kidney function 16 , which may be caused by the use of hormonal drugs, the patient's underlying diseases and the influence of psychological factors. The second reason is the difference in treatment methods during the rehabilitation period and its degree of emphasis. Academician also proposed a plan attaching importance to the rehabilitation of COVID-19 and hopes that it will be implemented, which reflects China's attention to this issue. Additionally, TCM has its own unique advantages for treatment during the rehabilitation period, such as the combination of multiple modalities, combining Chinese patent medicine with physical therapy, eliminating lingering pathogenic factors and supporting healthy qi 85 . commissions invited outstanding TCM experts to set up a task force for COVID-19. As early as July 24 th , 2021, many TCM experts adopted video conferences to carry out preliminary diagnosis and then exchanged ideas to develop specific and workable therapeutic regimens. Moreover, considering the changing features of the Delta variant, TCM experts propose that the immediate concern is now to give syndrome differentiation and treatment in TCM, prevent worsening of the condition, and help patients achieve a full recovery. The 'Prevention proposal of TCM for COVID-19 in Sichuan' was released to effectively manage the outbreak and its continued spread. Furthermore, although body temperature and inflammatory indicators have dropped to normal, symptoms have improved in many patients with Delta variant infection. TCM experts require that patients continue to take CHMs to strengthen body resistance, resolve toxins and prevent recurrence or progression.

From China to the whole world. According to many historical documents, TCM has historical origins in the prevention and treatment of epidemic diseases 86 . Currently, a large number of clinical practices have once again confirmed that early intervention with TCM and adherence to the integration of traditional Chinese and Western medicine can achieve relatively definite curative effects 87, 88 . At present, based on the domestic epidemic being under control, Chinese medical experts have brought many medical supplies, including Chinese patent medicines Lianhua Qingwen and Jinhua Qinggan, to Italy and other countries in need 89 . In the future, first, TCM experts can be sent abroad for consultation and assistance to provide TCM ideas for the treatment of diseases and to directly and concretely prove the effectiveness of TCM and its curative effects. Second, TCM schools in China can recruit foreign students to study TCM. Regarding the content of promotion, the first is to move the intervention forward, which the aim to achieve 'two early'. One is early intervention, mainly for close contacts and susceptible people, through the use of TCM to improve health, prevent and reduce infection. The other is early treatment, and early interventional treatment with TCM can effectively prevent mild cases from turning into severe cases 90 . Second, the integration of Chinese and Western medicine means promoting the consultation system of Chinese and Western medicine abroad, using the internet and -18 -other media to conduct remote consultations, exerting the advantages of TCM syndrome differentiation and choosing syndrome differentiation or disease differentiation according to the actual situation. Third, categorized treatment means using different treatment plans for the three stages of prevention, treatment and rehabilitation. Treatment of these three stages with TCM should also be extended to foreign countries, as the COVID-19 diagnosis and treatment plan has been updated to the eighth edition and classification of the stages and the corresponding treatment methods have become more detailed.

Transformation between clinical and basic. From clinical to basic research, at present, after the clinical efficacy of many Chinese patent medicines or compound prescriptions has been verified, basic research has been used to explore potential effective ingredients, targets and pathways to provide ideas for the development of specific drugs. From basic research to clinical application, basic research on the symptoms of COVID-19 shows that in the process of development, it will go through stages such as immune function decline and cytokine storm syndrome, and clinical treatments can be formulated based on this 91 . In TCM, in the early stage, the combination of internal and external TCM treatment can be used to support the body's healthy qi and improve immunity, and cytokine storms can be treated with heat-clearing and detoxifying drugs 92 .

Taken together, existing policies or regulations, clinical data, basic research and in silico studies have confirmed that TCM has made or is making great efforts in fighting the epidemic. Nevertheless, evidence supporting the use of TCM remains insufficient because TCM-related clinical trials are not progressing smoothly, and the current understanding of the mechanisms of TCM is mainly from molecular docking and network pharmacology analysis rather than in vitro and in vivo studies. Therefore, there is an urgent need for large-sample, multicenter and parallel controlled RCTs, as well as well-designed in vitro cell experiments and in vivo animal studies based on potential ingredients or extracts from CHMs, Chinese formulas, Chinese patent medicine, etc. Moreover, it is also important for the government to improve TCM recognition and acceptability at home and abroad with a series of efforts, such as perfecting education, cultivating talent, developing characteristics, inheriting 

World Health Organization. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data

The State Council Information Office of the People's Republic of China. Fighting Covid-19 China in Action

Discussion on the Advantages and Characteristics of TCM in the Prevention and Treatment of Pneumonia Caused by COVID-19

COVID-19: Discovery, diagnostics and drug development

National Administration of Traditional Chinese Medicine. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia

Historical Review and Reflection About Application of Traditional Chinese Medicine in Epidemic Diseases

Consideration of traditional Chinese medicine in treatment of highly pathogenic human coronaviruses SARS-CoV-2 and SARS-CoV

Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19)

The State Administration of traditional Chinese medicine establish a leading group for prevention and control of pneumonia in New Coronavirus infection

Beijing's first anti-epidemic traditional Chinese medicine preparation 'Huashi Baidu Granule' completed emergency filing

Shanxi: 5 kinds of Chinese medicine preparations to treat novel coronavirus pneumonia are included in the scope of medical insurance

The role of traditional Chinese medicine has become the highlight of China's plan, giving global anti-epidemic confidence

Academician Zhang Boli made Chinese medicine prescriptions for the world and shared Chinese experience with overseas counterparts

Wind and rain of China's assistance to foreign countries on five continents during the past 70 years. The People's Daily

Zeng Yong of West China Hospital: helping African countries fight the epidemic

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Academician Zhang Boli accepts an exclusive interview with Hubei reporters: most novel coronavirus pneumonia patients can recover from sequelae. Changjiang Daily

National Administration of Traditional Chinese Medicine. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia

National Administration of Traditional Chinese Medicine. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia

National Administration of Traditional Chinese Medicine. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia

Clinical Trial Ｒegistrations for COVID-19

Quality evaluation of clinical trial literatures on the COVID-19 treatment with traditional Chinese medicine(TCM)

Clinical trials for Traditional Chinese Medicine against coronavirus disease 2019 (COVID-19): Interpretation based on bibliometric analysis

Qingfei Paidu Decoction for Treatment of Mild

Moderate COVID-19 in 295 Cases: A Multi-Centered

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

Effect of Gengzi No.3 recipe on neutrophils to lymphocyte ratio of inner blocking causing collapse syndrome caused by severe COVID-19

Clinical Efficacy of Jinbei Oral Liquid in the Treatment of COVID-19 by Retrospective Analysi

Clinical observation of Jinqiang Xuanfei Jiedu Mixture in treating COVID-19

Characteristics of clinical trials of novel coronavirus pneumonia in China

Research progress of target method of Chinese medicine

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro

Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding

CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach

Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome-and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion

Uncaria tomentosa (cat's claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling

Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63

Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future

Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor

Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein

Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells

The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL(pro) from Ginkgo biloba leaves via large-scale screening

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases

Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition

Effective inhibition of MERS-CoV infection by resveratrol

Emodin inhibits current through SARS-associated coronavirus 3a protein

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Research progress on immunomodulatory effect of Chinese materia medica andprescriptions on viral pneumonia. Chinese Traditional and Herbal -26

Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19

Intervening Effect of Promoting Lung and Resolving Phlegm Method on Mouse Model Combining Disease and Syndrome of Human Coronavirus Pneumonia with Cold-dampness Pestilence Attacking Lung

Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function

Effect of matrine sodium chloride injection on a mouse model combining disease with syndrome of human coronavirus pneumonia with cold-dampness pestilence attacking the lung

Cytokine release syndrome in severe COVID-19

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

COVID-19: consider cytokine storm syndromes and immunosuppression

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies

KD-1) exerts anti-viral and antiinflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus

HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway

Liu Shen capsule shows antiviral and antiinflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study

Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study

Research progress and application strategy on network pharmacology in chinese materia medica

Exploration of the characteristic and molecular mechanism of Chinese herbal medicines in the coreformula for COVID-19's cases based on data mining and network pharmacology

Exploring active compounds of Da-Yuan-Yin in treatment of COVID-19 based on network pharmacology and molecular docking method

Progress in clinical research on prevention and treatment of novel coronavirus pneumonia by external therapy of traditional Chinese medicine

Provide Chinese solutions for the rehabilitation of novel coronavirus pneumonia

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

Discussion on the Theory of Traditional Chinese Medicine Regulating the Immune Function of Coronavirus Pneumonia Patients During Recovery Period and Discharged from Hospital World Science and Technology-Modernization of

Opportunities and Challenges of Development of Traditional Chinese Medicine Based on Its Anti-Epidemic Background

Effect of Intervention-timing of Traditional Chinese Medicine on the Recovery Time of COVID-19 Based on Real world

Application of integrative medicine protocols in treatment of coronavirus disease 2019

Chinese medicine go overseas to fight the epidemic! A large number of Lianhua Qingwen and Jinhua Qinggan donated to Italy and Iraq

Academician Tong Xiaolin: Traditional Chinese medicine has played an important role in the control of the COVID-19 epidemic. I hope that the children will love the culture of traditional Chinese medicine

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Basic study on treatment of

with Shufeng Jiedu Capsule and research and development ideas of new Chinese materia medica against COVID-19